ADAGENE INC. - ADS EACH REPRESENTING 1.25 ORDINAR
2.3900
22-8月-25 13:45:00
15 分の遅延
株式
+0.1100
+4.82%
本日の幅
2.2200 - 2.5500
ISIN
N/A
ソース
NASDAQ
-
Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update
25 7 2024 13:05:00 提供 Nasdaq GlobeNewswire
-
Adagene to Present at Investor Conferences in June
22 5 2024 13:45:00 提供 Nasdaq GlobeNewswire
-
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
29 3 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board
07 3 2024 13:01:00 提供 Nasdaq GlobeNewswire
-
Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
27 2 2024 05:00:01 提供 Nasdaq GlobeNewswire
-
09 2 2024 03:00:00 提供 Nasdaq GlobeNewswire
-
04 1 2024 02:00:00 提供 Nasdaq GlobeNewswire
-
03 11 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
Adagene to Present at Investor and Scientific Conferences in September
07 9 2023 03:00:00 提供 Nasdaq GlobeNewswire
-
Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
31 8 2023 04:32:21 提供 Nasdaq GlobeNewswire
-
04 5 2023 06:00:01 提供 Nasdaq GlobeNewswire
-
Adagene Announces Updates to its Board of Directors
28 4 2023 04:00:11 提供 Nasdaq GlobeNewswire
-
Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update
28 3 2023 13:30:06 提供 Nasdaq GlobeNewswire
-
14 3 2023 15:00:00 提供 Nasdaq GlobeNewswire
-
Adagene Appoints Professor Aurélien Marabelle to Scientific and Strategic Advisory Board
05 3 2023 16:39:30 提供 Nasdaq GlobeNewswire